Hemminki, Kari
Försti, Asta
Chen, Tianhui
Hemminki, Akseli
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 2 September 2021
Accepted: 20 October 2021
First Online: 8 November 2021
Declarations
:
: Aggregated data from a publically accessible database were used posing no ethical issues.
: Not applicable.
: A.H. is shareholder in Targovax ASA. A.H. is employee and shareholder in TILT Biotherapeutics Ltd. Other authors declared no conflict of interest.